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Interaction between virulence factors of Streptococcus pneumoniae and innate immune
receptors elicits host responses through specific signaling pathways during infection.
Insights into the signaling events may provide a better knowledge of the starting events
for host-pathogen interaction. Here we demonstrated a significant induction of innate
immune response elicited by recombinant S. pneumoniae endopeptidase O (rPepO), a
newer pneumococcal virulence protein, both in vivo and in vitro. Intratracheal instillation
of rPepO protein resulted in significant increase of cytokines production and neutrophils
infiltration in mouse lungs. TLR2 or TLR4 deficient mice subjected to rPepO treatment
showed decreased cytokines production, reduced neutrophils infiltration and intensified
tissue injury as compared with WT mice. Upon stimulation, cytokines TNF-α, IL-6,
CXCL1, and CXCL10 were produced by peritoneal exudate macrophages (PEMs) in a
TLR2 and TLR4 dependent manner. rPepO-induced cytokines production was markedly
decreased in TLR2 or TLR4 deficient PEMs. Further study revealed that cytokines
induction relied on the rapid phosphorylation of p38, Akt and p65, not the activation
of ERK or JNK. While in TLR2 or TLR4 deficient PEMs the activation of p65 was
undetectable. Taken together, these results indicate for the first time that the newer
pneumococcal virulence protein PepO activates host innate immune response partially
through TLR2 and TLR4 signaling pathways.
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INTRODUCTION
Streptococcus pneumoniae, a gram positive bacterium, asymptomatically colonizes the upper
respiratory airway and causes common clinical syndromes such as otitis media, sinusitis, bronchitis,
and empyema or even severe life-threatening diseases including pneumonia, meningitis, and
septicemia (van Der Poll and Opal, 2009; Cole et al., 2014). S. pneumoniae infections have led to
significant morbidity and mortality worldwide especially in children under 5 years old and the
elder over 65 years old in developing countries (O’Brien et al., 2009). Main approaches to prevent
and treat diseases caused by S. pneumoniae are using effective vaccines and antibiotics. However,
Zhang et al. rPepO-Induced Innate Immune Response
what challenge us most is the fast development of antibiotic-
resistant S. pneumoniae strains and the existence of a number
of problems with the application of vaccines. Pneumococcal
polysaccharide vaccine and capsular polysaccharide (CPS)–
protein conjugate vaccine (PCV) protect people against serotypes
but give rise to the risk for natural serotype switching (Kadioglu
et al., 2008; Goncalves et al., 2014). Protein-based vaccine
could avoid the problem of poor polysaccharide immunogenicity
among infants and elderly people and would probably protect
host from most pneumococcal strains (Kadioglu et al., 2008;
Liu et al., 2014). Therefore, it is worthwhile for researchers to
discover novel virulence factors and to illustrate the interaction
between virulence factors and host, which may contribute to the
development of anti-bacterial drugs and may broaden the scope
of researches on protein vaccines.
S. pneumoniae endopeptidase O (PepO) is a novel discovered
72KD protein and a predicted metallo-endopeptidase
sharing homology with M13 peptidase family. Mammalian
endopeptidases, a member of M13 peptidase family, involve
in regulation of many physiological and pathological progress
including various aspects of immune response. In the content
of pneumococcal PepO, Agarwal and colleagues have proved
that PepO promotes S. pneumoniae evade host innate immunity
and invade host cells through binding to plasminogen and
fibronectin (Agarwal et al., 2013). They further demonstrated
that PepO binds to complement C1q, modulating the attack by
complement and promoting adherence to host cell (Agarwal
et al., 2014). A PepO-deficient strain showed decreased ability
to adherent to and invade host cells compared with its wild-type
strain. Thus, involvement of PepO in virulence has been well
illustrated. Whether and how PepO activates Toll-like receptors
(TLRs) or other pattern recognition receptors (PRRs) are still
not known. Research on the effect of PepO on host immune
response will provide us a better knowledge of the starting events
for host-pathogen interaction.
The innate immune response builds up the first line of defense
response against bacterial invasion. As important innate immune
cells, macrophages respond immediately to diverse microbial
pathogens and quickly control the replication of the invading
pathogen (Medzhitov and Janeway, 2000; Hato and Dagher,
2014; Elia et al., 2015). Microbial components could initiate
the innate immune response through ligating to PRRs such as
NOD-like receptors and TLRs (Politis and Vogel, 2005; Brekke
et al., 2007; Groves et al., 2008). Recognition of peptidoglycan
from Gram-positive bacteria by TLR2 or lipopolysaccharide
(LPS) from Gram-negative bacteria by TLR4 is universally
accepted. The binding of ligands to TLRs could trigger signal
cascade resulting in secretion of inflammatory cytokines that are
mediated by phosphorylation of MAPKs, IFN regulatory factors,
and NF-κB (Medzhitov, 2007). Three types of MAPKs- ERK,
JNK, and p38 are activated independently or simultaneously in
mammalian cells. Phosphatidylinositol 3-kinases (PI3Ks) can be
activated during TLR signaling through direct interaction with
the receptor or adaptor molecular TIRAP orMyD88, which leads
to the phosphorylation of its downstream target, Akt, and the
activation of NF-κB (Akira and Takeda, 2004; Santos-Sierra et al.,
2009).
It is demonstrated that the pneumococcal virulent proteins
directly participate in pathogenesis through interacting with the
host innate immune system (Kawai and Akira, 2011; Dong et al.,
2014). For example, pore-forming cytolysin pneumolysin (Ply)
is known as a major virulence determinant of S. pneumoniae,
conferring protection from complement-mediated clearance and
promoting S. pneumoniae crossing through the epithelial barrier
and establishing invasive infections (Yuste et al., 2005; Gauthier
et al., 2007; Marini et al., 2014). In contrast, this key virulence
protein can become the focus of host innate immune system,
inducing inflammatory and apoptotic events via TLR4, which
optimizes pathogen clearance (Srivastava et al., 2005; Shoma
et al., 2008; Bewley et al., 2014). In addition, other pneumococcal
virulence proteins such as adherence and virulence factor A
(PavA), RrgA Pneumococcal Pilus Type 1 Protein and glycosyl
hydrolase 25 participating in invasion protein (GHIP) have
been reported to be essential factors for bacterial virulence and
induction of optimal cytokines production by innate immune
cells (Noske et al., 2009; Basset et al., 2013; Dong et al., 2014).
Despite these advances, research on the innate immune response
induced by pneumococcal virulence proteins and the related
molecular mechanisms is still limited. Further clarification is
needed, particularly for these new virulence factors.
In the present research, we have explored the roles of rPepO in
activation of innate immunity, as well as the involved molecular
mechanism.
MATERIALS AND METHODS
Reagents
Escherichia coli K12- derived ultra-purified LPS was obtained
from InvivoGen (San Diego, CA). Anti-PepO antibody was from
mice immunized with rPepO. Mouse anti-actin monoclonal
antibody was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Rabbit anti- phospho- MAPKs, anti-
phospho- P65, anti- phospho- Akt, anti-MAPKs, anti-Akt,
and anti-lamin B monoclonal antibodies were bought from
Cell Signaling Technology (Beverly, MA). P38 inhibitor
SB203580, ERK inhibitor U0126, JNK inhibitor SP600125, IκB-α
phosphorylation inhibitor BAY11-7082, Janus kinase inhibitor
AG490,and PI3K inhibitor LY294002 were purchased from
Cell Signaling Technology. AG490, SP600125, PD98059, and
BAY117082 were dissolved in DMSO, while LY294002 and
SB203580 were dissolved in endotoxin-free water.
Preparation of Recombinant Protein PepO
The details were as Vaibhav Agarwal and colleagues described
earlier (Agarwal et al., 2013). Briefly, the full-length pepO
gene was obtained by PCR from D39 chromosomal DNA
with primers 5-CCATGGCACGTTATCAGATGATTT-3 and 5-
CTCGAGCCAAATAATCACGCGCTC-3, which incorporated
flanking NcoI and XhoI (underlined) restriction sites. The
amplified DNA was cloned in pJET1.2 (Fermentas) and later
into pET28a (Novagen) for protein expression, after which
pneumococcal PepO with an N-terminal His6 tag was expressed
in E. coli BL21 (DE3) (Stratagene) and purified using a nickel-
nitrilotriacetic acid column (GE healthcare) according to the
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manufacture’s instruction. Then endotoxin-free plastic ware,
glassware, and water were used. To remove lipopolysaccharide
(LPS) from rPepO preparation as much as possible, protein
fractions were incubated with polymyxin B (PmB)—agarose
(Sigma, Santa Clara, CA) with end-over-end rotation at 4◦C
overnight. Residual LPS in the rPepO preparation was measured
by the Limulusamoebocyte lysate (LAL) assay (Lonza), following
the manufacturer’s instructions. rPepO purity was determined
using Coomassie Blue Staining. Aliquots were stored at −80◦C
until they were used. To exclude the effects of contaminated LPS,
the rPepO preparation was incubated with 100µg/ml PmB at
37◦C for 2 h or pretreated with 50µg/ml proteinase K at 37◦C
for 1 h (Byun et al., 2012; Wen et al., 2014).
Isolation of PEMs
Six- to eight-weeks-old C57BL/6 and TLR2/TLR4-deficient mice
were injected intraperitoneally with 1ml paroline. 4 days later,
cells were recovered from euthanized mice by peritoneal lavage
using 13ml sterile PBS containing 5mM EDTA. Cells were
washed with Dulbecco’s Modified Eagle Medium (DMEM) and
seeded in tissue culture plates (5 × 105/well for 24-well plate,
1 × 106/well for 6-well plate). After 60min, cells in tissue
culture plates were washed with sterile PBS twice to remove non
adherent cells. Recovered adherent cells were grown in DMEM
supplemented with 1% penicillin-streptomycin and 10% fetal
bovine serum (FBS) (HyClone, Barrington, USA) and stimulated
as described below.
Mouse Model of Intratracheal Instillation of
rPepO
TLR2/TLR4 deficient (TLR2KO/TLR4KO) mice were bought
from The Jackson Laboratory (Bar Harbor, ME). Every mouse
is on a C57BL/6 background. Experimental protocols involving
animals were approved by the Animal Ethics and Research
Committee of China University Graduate School of Medicine.
Mice were 6–8 weeks old during experiments and were fed with
standard rodent water and chow. All mice were not fasted prior to
experiments. During experiments, each mouse was anesthetized
with 80µl pentobarbital. A mid ventral incision was performed.
After isolation of muscles, the trachea was exposed. Then it was
instilled with 50µl rPepO (1mg/ml) or 50µl endotoxin-free PBS.
At 24 h post instillation, every experimental mouse was humanely
sacrificed to collect bronchoalveolar lavage fluid (BALF) or lung
tissue, respectively. 2.5ml sterile PBS was used to perform BALF.
RNA Extraction and PCR Analysis
Total RNA was extracted from PEMs by RNAiso plus reagent
(Takara) following manufacturer’s instructions. Real-time PCR
was performed in a Bio-Rad real time PCR machine with the
use of SYBR Green detection protocol. All primers used were
purchased from Sangon (Shanghai, China). Their sequences
were listed below: β-actin, sense: 5′-TGCTGTCCCTGTATGC
CTCT-3′, antisense: 5′-GGTCTTTACGGATGTCAACG-3′;
TNF-a, sense: 5′-GGCGGTGCCTATGTCTCA-3′, antisense:
5′-GGCAGCCTTGTCCCTTGA-3′; IL-6, sense: 5′-TGCCTT
CTTGGGACTGAT-3′, antisense:5′-CTGGCTTTGTCTTTCT
TGTT-3; CXCL1, sense: 5′-ACTCAAGAATGGTCGCGAGG-3′,
antisense: 5′-GTGCCATCAGAGCAGTCTGT-3′; CXCL10,
sense: 5′-CTGAGTCCTCGCTCAAGTGG-3′, antisense: 5′-CTA
GGGAGGACAAGGAGGGT-3′; TLR2, sense: 5′-GAGCATCCG
AATTGCATCACC-3′, antisense: 5′-CCCAGAAGCATCACAT
GACAGAG-3′; TLR4, sense: 5′- TTCAGAACTTCAGTGGCTG
GATTTA-3′, antisense: 5′-GTCTCCACAGCCACCAGATT
CTC-3′; After amplification protocol ended, Bio-Rad software
was used for melt curve analysis of the PCR product. The gene
for β-actin was used as an endogenous reference. Both relative
delta delta Ct and a standard curve were used for determining
quantification.
Measurement of Cytokines and
Chemokines
Cytokines and chemokines in BALF, lung homogenate, and
cell culture medium were measured using ELISA kit for IL-
6, TNF-α, and IL-17 (Biolegend), for CXCL10 (eBioscience),
for CXCL1 (Biosepses), respectively, following the manufacture’s
instruction. In cell studies involving inhibitors, PEMs were
pretreated with p38 inhibitor SB203580 (30µM), ERK inhibitor
U0126 (50µM), JNK inhibitor SP600125 (40µM), IκB-α
phosphorylation inhibitor BAY11-7082 (20µM), Janus kinase
inhibitor AG490 (10µM),or PI3K inhibitor LY294002 (20µM)
for 1 h at 37◦C. The cells were then stimulated with rPepO for
another 24 h at 37◦C.
Histology
Mice for histological analyses were anesthetized with lethal
doses of pentobarbital followed by intratracheal infusion with
4% paraformaldehyde (PFA) at 24 h post instillation. The lung
tissues were dissected and fixed (4% PFA) overnight. Serial 5-µm
paraffin sections of lung tissues were stained by hematoxylin-
eosin and observed with a lightmicroscope (Liu et al., 2014). Cells
in BALF from WT, TLR2-deficient or TLR4-deficient mice were
diluted and stained with Wright-Giemsa dye.
Flow Cytometry Analysis
Cells in BALF were collected and fixed with 4% PFA for 15min.
After washing with precooled PBS, cells were re-suspended with
Fc Block (BD Pharmingen, San Diego, CA) at a dilution of 1:100
in PBS and incubated on ice for 60min. Then the cells were
probed in the dark with corresponding APC-conjugated anti
CD11b (eBioscience), FITC- conjugated anti Ly6G (eBioscience),
PE-conjugated anti F4/80 (eBioscience), or appropriate isotype
control Ab (eBioscience) for 1 h on ice. Labeled cells were
analyzed by a FACS calibrator counting 10,000 events per sample.
Immunofluorescence Assays
PEMs were seeded on poly-l-lysine -coated glass coverslips
overnight. After stimulation with rPepO (10µg/ml) for indicated
time, cells on coverslips were fixed with 4% PFA for 15min,
permeabilized with 0.1% Triton X-100 for 5min, and blocked
with 2% BSA in PBS for 2 h. Then these cells were probed with
anti-histidine antibody or anti-NF-κB P65 antibody for 2 h at
room temperature. After washing in PBS, the cells were incubated
with Alexa 594 or 488-conjugated secondary antibody in a dark
room for 1 h and were then stained with DAPI for 5min at room
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FIGURE 1 | Preparation of rPepO and experiments to exclude the contamination of LPS in rPepO preparation. (A) rPepO (lane 2) was subjected to 10%
SDS-PAGE and detected by Coomassie brilliant blue staining. Lane 1, protein marker or pre- stained marker. (B) Proteins from various pneumococcal serotype
isolates were detected by anti-rPepO antibody using western bolt analysis. 5, 2, 3, TIG4, 6B, 14, 19F, 23F mean various pneumococcal serotypes. (C) rPepO
(10µg/ml) preparation and LPS (100 ng/ml) were digested with proteinase K (50µg /ml) for 1 h or incubated with PmB (100µg/ml) for 2 h at 37◦C prior to adding to
PEMs. TNF-α and IL-6 levels in culture medium were determined by ELISA. The data are shown as the mean ± SD (n = 3). Student’s t-test was performed to
calculate the statistical significance (***p < 0.001; ns, not significant).
temperature. Cell morphology and fluorescence intensity were
observed with a Nikon ECLIPSE 80i microscope equipped with
a Nikon INTENSILIGHT C-HGFI.
Western Blot Analysis
Various pneumococcal serotype isolates were grown in C+Y
medium and collected. After washing with pre chilled PBS, PEMs
were lysed with lysis buffer (RIPA containing phosphorylase
inhibitor and protease inhibitor mixed with SDS loading buffer)
for 15–30min on ice and boiled for 5min. Before transferring to a
PVDF membrane (Millipore, Bedford, MA), the same volume of
lysate (10µg) was separated by 10% SDS–PAGE. After blocking
with 5% defatted milk for 2 h at 37◦C, the membrane was
probed with indicated antibody at 4◦C overnight. The membrane
was washed for three times, and incubated with appropriate
secondary goat anti-rabbit or goat anti-mouse antibodies for 1 h
at 37◦C. Then an ECL western blotting detection system was
used to detect antibody–antigen complexes. Band intensity was
quantified by Quantity one software (Bio-Rad, Hercules, CA) to
determine protein expression.
Statistical Analysis
All data were shown as mean ± SD of triplicate samples.
Differences between groups were determined by Student’s
t-test or ANOVA followed by Tukey’s test with the use of
GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA).
For all experiments, statistical significance was considered as
P-values < 0.05.
RESULTS
Preparation of rPepO and Experiments to
Exclude the Contamination of LPS in
rPepO Preparation
The overexpressed rPepO was subjected to 10% SDS-PAGE
and stained with coomassie blue. Figure 1A showed a single
protein with the expected size, of which the purity was above
90%. Western blot analysis showed that the same size protein
from various pneumococcal serotype isolates can be recognized
by anti-rPepO antibody (Figure 1B), which further proves
the correct expression of rPepO. LPS, a TLR4 agonist, is
able to induce strong cytokine production (e.g., IL-6, TNF-
α). Even though the final concentration of LPS in rPepO
preparation was under 0.1 endotoxin units (EU)/ml, to avoid
its effect, experiments to exclude the contamination of LPS
were performed. PEMs stimulated with PmB-incubated rPepO
secreted equal volume of IL-6 and TNF-α compared with cells
stimulated with untreated rPepO. However, PEMs treated with
protease K digested rPepO produced little IL-6 and TNF-α.
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FIGURE 2 | rPepO elicits strong innate immune response in lungs of C57BL/6 WT mice. WT mice were intratracheally instilled with 50µl rPepO (1mg/ml) or
50µl endotoxin-free PBS. The mice were humanely sacrificed at 24 h post instillation. (A) Total RNA was extracted from lung tissues and PCR analysis was used to
assess the transcripts of cytokines. Cytokines production in Lung tissue (B) and BALF (C) were measured by ELISA. (D) Paraffin sections of the lung tissues were
stained with hematoxylin –eosin (original magnification, ×20). (E) The number of nucleated cells in BALF was counted under light microscope. The cell types in BALF
were analyzed by flow cytometry analysis (F) and Wright-Giemsa staining (G). The data are shown as the mean ± SD (n = 3). Student’s t-test was performed to
calculate the statistical significance (*p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant).
At the same time, IL-6 and TNF-α induced by protease K
digested LPS was equal to that induced by untreated LPS, while
PmB-incubated LPS induced little release of IL-6 and TNF-
α (Figure 1C). Taken together, these results suggested that the
rPepO preparation contained too little LPS to influence our
experiments.
rPepO Elicits Strong Innate Immune
Response in Lungs of C57BL/6 WT Mice
To investigate the effect of rPepO on activation of host innate
immunity, we constructed a mouse model of intratracheal
instillation. C57BL/6 WT mice were intratracheally instilled
with rPepO or endotoxin-free PBS. 24 h later, IL-6, TNF-α,
CXCL1, and CXCL10 transcripts in lung tissues of rPepO
administrated mice were significantly up-regulated compared
with that of PBS administrated mice (Figure 2A). Consistently,
protein levels of IL-6, TNF-α, CXCL1, and CXCL10 in lung
homogenate and BALF of rPepO challenged mice were higher
than that of PBS challenged mice (Figures 2B,C). Histology
analysis showed that a number of cells were recruited to
alveolar lumen of rPepO treated mice (Figure 2D). As shown
in Figure 2E, the number of nucleated cells in BALF of rPepO
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 February 2016 | Volume 6 | Article 23
Zhang et al. rPepO-Induced Innate Immune Response
FIGURE 3 | rPepO– induced innate immune response is dependent on TLR2 and TLR4. WT, TLR4 deficient and TLR2 deficient mice were intratracheally
instilled with rPepO or PBS. 24h later, cytokines production (TNF-α, IL-6, CXCL1 and CXCL10) in lung homogenate (A) and in BALF (B) were measured by ELISA.
(C) Pictures of lung tissues were taken. (D) Paraffin sections of the lung tissues were stained with hematoxylin –eosin (original magnification, ×20). (E) The number of
nucleated cells in BALF of rPepO stimulated mice was counted under light microscope. The cell types in BALF were analyzed by flow cytometry analysis (F) and
Wright-Giemsa staining (G).The data are shown as the mean ± SD (n = 3). ANOVA followed by Tukey’s test was performed to calculate the statistical significance
(*p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant).
stimulated mice was much more than that of PBS stimulated
mice, with a mean increase of 10-fold. Flow cytometry analysis
and Wright-Giemsa staining analysis demonstrated that 90.92%
recruited nucleated cells in BALF from rPepO treated mice were
neutrophils, while 90.64% nucleated cells in BALF from PBS
treated mice were macrophages (Figures 2F,G). These results
indicated the significant activation of mouse innate immunity
by rPepO.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 February 2016 | Volume 6 | Article 23
Zhang et al. rPepO-Induced Innate Immune Response
rPepO-Induced Innate Immune Response
is Partially Dependent on TLR2 and TLR4
It has been proved that many pneumococcal proteins are sensed
by TLR2 or TLR4, such as RrgA Pneumococcal Pilus Type 1
Protein, GHIP, Ply and so on (Malley et al., 2003; Basset et al.,
2013; Dong et al., 2014). To investigate whether TLR2 and TLR4
participate in the recognition of rPepO, mouse models with
TLR2 or TLR4 deficient mice were used. WT, TLR2 deficient
and TLR4 deficient mice were intratracheally instilled with
rPepO or endotoxin-free PBS. 24 h later, volume of TNF-α, IL-
6 and CXCL10 in lung homogenate and BALF from rPepO
stimulated TLR4 deficient mice was significantly less than that
from rPepO stimulated WT mice. CXCL1 in lung homogenate,
not in BALF of rPepO stimulated TLR4 deficient mice was
reduced compared with that of rPepO stimulated WT mice
(Figures 3A,B). Protein levels of IL-6, TNF-α, and CXCL10
in BALF from rPepO stimulated TLR2 deficient mice were
obviously declined compared with that from rPepO stimulated
WT mice, while in cytokines production of lung homogenate
there was no significant difference between rPepO stimulated
TLR2 deficient mice andWTmice (Figures 3A,B). Figures 3C,D
showed that rPepO treated TLR2 or TLR4 deficient mice
suffered intensified tissue injury. As shown in Figure 3E, the
number of nucleated cells in BALF of rPepO administrated
TLR4 deficient mice was significantly less than that of rPepO
administrated WT mice, and there existed no significant
difference between rPepO administrated TLR2 deficient mice
and WT mice, which was consistent with the outcome of
cytokines production in lung homogenate. Flow cytometry
analysis and Wright-Giemsa staining analysis illustrated that the
proportion of neutrophils in BALF of rPepO stimulated TLR4
deficient mice was declined, with a percentage of 68.36%. And
there was no significant difference in proportion of neutrophils
between rPepO stimulated TLR2 deficient mice and WT mice
(Figures 3F,G). These results suggested that rPepO-induced
innate immune response might play a protective role during
pneumococcal infection and TLR4 may predominate in sensing
rPepO. We were wondering how tissue injury in TLR2 and TLR4
deficient mice could occur without the inflammatory effects
reported withWTmice. Other effects of rPepO such as fibrinogen
binding or endopeptidase activity may participate in destroying
the integrity of lung tissues.
rPepO Induces Cytokines Production in
PEMs
Macrophages are key cells of the host innate immune system,
so we focused our investigation on the effect of rPepO
on macrophages in vitro. Primary PEMs were cultured and
stimulated with different concentrations of rPepO. To be
consistent with our mouse model we evaluated cells 24 h after
rPepO treatment. 24 h later, viability of PEMs was above 95%
(data not shown) as assessed by trypan blue exclusion staining,
and secretion of IL-6, TNF-α, IL-17A increased in a dose-
dependent manner (Figures 4A–C). And we chose concentration
(10µg/ml) of rPepO for subsequent experiments. After exposure
to rPepO, release of IL-6, TNF-α, CXCL1, CXCL10 was
dramatically augmented, both at the mRNA (Figure 4D) and
protein level (Figure 4E).
FIGURE 4 | rPepO induces cytokines production in PEMs. (A–C) PEMs were treated with different dosages of rPepO or LPS (100 ng/ml) for 24 h, and IL-6,
TNF-α, IL-17 in culture medium were determined by ELISA. (D) Total RNA was extracted from PEMs stimulated with rPepO (10µg/ml) for 6 h and PCR analysis was
used to measure the transcripts of cytokines. (E) Cytokines in culture medium of PEMs stimulated with rPepO (10µg/ml) or LPS (100 ng/ml) for 24 h were measured
by ELISA. The data are shown as the mean ± SD (n = 3). Student’s t-test was performed to calculate the statistical significance (*p < 0.05; ***p < 0.001; ns, not
significant).
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rPepO-Induced Cytokines Production in
PEMs is Mediated by TLR2 and TLR4
After exposure to rPepO, both TLR2 and TLR4 transcripts
were up-regulated in PEMs (Figure 5A). Upon stimulation
TLR2 or TLR4 deficient PEMs showed impaired secretion
of cytokines and chemokines, both in mRNA and protein
analyses (Figures 5B,C), suggesting that both TLR2
and TLR4 participated in the activation of rPepO on
macrophages.
rPepO Induces Phosphorylation of MAPKs,
Akt and NF-κB P65 via TLR2 and TLR4
Signaling
The phosphorylation of MAPKs and Akt in PEMs stimulated
by rPepO for different times were determined by western blot
analysis. As shown in Figures 6A–D, rPepO induced a strong
phosphorylation of MAPKs and Akt after 5–15min stimulation,
with a peak phosphorylation appearing at 10–15min. In
untreated cells little phosphorylated proteins were detected. The
duration of p38 signaling response in TLR4 deficient PEMs
was significantly less than that in WT or TLR2 deficient PEMs.
While in TLR2 deficient cells activation of Akt was delayed
but increased. Figure 7A showed the translocation of NF-κB
p65 to nucleus of rPepO–treated WT PEMs. P65 was primarily
present in the cytoplasm of unstimulated cells. While in TLR2
or TLR4 deficient cells, rPepO failed to induce the nuclear
translocation of p65. Western blot analysis also demonstrated
the phosphorylation of p65 in rPepO-stimulated WT cells
(Figure 7B). While in TLR2 deficient cells, the phosphorylated
p65 was undetectable. It is worth noting that p65 signaling
analysis showed more ablated effects with TLR2 deficient cells
than necessarily TLR4 deficient cells. Taken together, in TLR2 and
TLR4 deficient cells the alteration of activation of intracellular
signaling molecular may account for their impaired cytokines
secretion.
rPepO-Induced Cytokines Production
Depends Primarily on the Activation of p38,
Akt and NF-κB
PEMs were pretreated with appropriate amount of SB203580,
U0126, SP600125, LY294002, AG490, or BAY11-7082 for 60min,
and stimulated by rPepO for another 24 h. TNF-α, IL-6,
CXCL1 and CXCL10 in cell culture medium were measured
by ELISA. Production of TNF-α, IL-6, CXCL1 was partially
blocked by p38 inhibitor and PI3K inhibitor (50–70% inhibition),
and significantly blocked by IκB-α phosphorylation inhibitor
(above 90% inhibition) (Figures 8A–C). CXCL10 production was
prominently blocked by NF-κB inhibitor and PI3K inhibitor
(Figure 8D). Inhibitors of ERK, JNK, and JAK failed to
influence the rPepO-induced cytokines production in PEMs
(Figures 8A–D).
DISCUSSION
Recognition of microbial components by the innate immune
system is an effective method to protect the host from
various pathogens (Hoffmann et al., 1999). Pneumococcal PepO
is a novel virulence factor, ubiquitously present in various
pneumococcal isolates. Our results demonstrated that rPepO can
activate host innate immune response against S. pneumoniae,
inducing the production of TNF-α, IL-6, CXCL1, and CXCL10
both in vivo and in vitro. Cytokines play an important role
in host defense against S. pneumoniae. TNF-α contributes
to inhibiting the growth and transmission of pneumococci
(van Der Poll et al., 1997a), which is mediated mainly by
the TNF type I receptor (Kerr, 2002). Furthermore, during
pneumococcal pneumonia TNF-α could compensate for the
attenuated host defense response in type I IL-1 receptor-
deficient mice (Rijneveld et al., 2001). IL-6 also protects host
from pneumococcal infection through reducing the growth of
pneumococci and prolonging survival (van Der Poll et al.,
1997b). CXCL1 promotes neutrophils trafficking into lung tissue,
which predominate the cellular infiltrates during pneumococcal
pneumonia (Gauthier et al., 2007; Griffith et al., 2014). IL-17
was produced by rPepO stimulated PEMs, which also contributes
to neutrophils trafficking (McAleer and Kolls, 2014). CXCL10
accelerates lymphocytes trafficking to dendritic cells (DCs) for
priming and initiating adaptive immune response (Yoneyama
et al., 2002; Griffith et al., 2014). In our model, INF-γ was
not detectable (data not shown), maybe suggesting a protective
role of rPepO-induced cytokines production, there is evidence
showing that INF-γ inhibited antibacterial defense in models
of either primary or post influenza pneumococcal pneumonia
(Rijneveld et al., 2002; Sun and Metzger, 2008). Nevertheless,
further research is still needed to identify the exact role played
by the rPepO-induced cytokines production.
TLR2 and TLR4 are responsible for recognition of various
kinds of microbial components. In the content of S. pneumonia,
lipoproteins/lipopeptides, peptidoglycan, glycopolymers
(lipoteichoic acid and lipoarabinomannan) and proteins (RrgA
Pneumococcal Pilus Type 1 Protein, GHIP) have been shown to
be TLR2 ligands (Paterson and Mitchell, 2006; Basset et al., 2013;
Dong et al., 2014). Ply is a universally accepted agonist of TLR4.
Our work illustrated that rPepO-induced cytokines production
was mediated both in part by TLR2 and TLR4, and this is the first
demonstration of both TLR2 and TLR4 mediated recognition
of pneumococcal protein. Upon stimulation, TLR2 and TLR4
transcripts were up-regulated in WT PEMs. After treated with
equal amount of rPepO, TLR2, or TLR4 deficient PEMs produced
much less cytokines than WT PEMs did, both at mRNA and
protein levels. In addition, in mouse model TLR4 deficient
mice showed significantly decreased cytokines production,
reduced neutrophils infiltration and intensified tissue injury
compared with WT mice. While TLR2 deficient mice only
showed decreased cytokines secretion in BALF accompanied by
severer tissue injury. These results imply a protective role played
by TLR2 and TLR4 in rPepO induced activation of host innate
immunity. Previous study has proved that TRAM-dependent
TLR4 signaling protect the host from endotoxic shock, which
is controlled by p110δ of PI3K (Aksoy et al., 2012). In our
model, whether rPepO induces a regulatory protective response
via PI3K/Akt still needs further clarification. In mouse lungs
rPepO –induced innate immune response is mainly mediated
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FIGURE 5 | rPepO - induced cytokines production in PEMs is mediated by TLR2 and TLR4. (A) RNA was extracted from PEMs stimulated with rPepO
(10µg/ml) for 6 h and PCR analysis was used to determine TLR2 and TLR4 transcripts. (B) RNA was extracted from WT, TLR4, or TLR2 deficient cells stimulated by
(Continued)
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FIGURE 5 | Continued
rPepO (10µg/ml), LPS (100 ng/ml) or PGN (5µg/ml) for 6 h and cytokines transcripts were evaluated by PCR analysis. (C) Cytokines in culture medium of WT, TLR2,
or TLR4 deficient PEMs exposed to rPepO (10µg/ml), LPS (100 ng/ml) or PGN (5µg/ml) for 24 h were determined by ELISA. The data are shown as the mean ± SD
(n = 3). Student’s t-test was performed to calculate the statistical significance (*p < 0.05; ***p < 0.001; ns, not significant).
FIGURE 6 | rPepO induces phosphorylation of MAPKs and Akt via TLR2 and TLR4 signaling. (A–D) WT, TLR2 or TLR4 deficient PEMs were incubated with
rPepO (10µg /ml) for the indicated times (0–60min). Cell lysates were prepared, and western blot analysis was used to determine the phosphorylation of p38, Erk,
JNK, and Akt. Representative blots of three independent experiments with consistent outcome are shown. The relative band intensities of three tests are shown in
histograms above. The data are shown as the mean ± SD (n = 3). Student’s t-test was performed to calculate the statistical significance (*p < 0.05; **p < 0.01;
***p < 0.001).
by TLR4. Other pulmonary cells may participate in rPepO-
induced cytokines production via TLR4, which accounts for the
disagreement of cytokines production between TLR2 deficient
PEMs and mice. Previous study has shown that TLR4 signaling
can induceTLR2 expression in endothelial cells (Fan et al., 2003).
Whether crosstalk between TLR2 and TLR4 signaling occurs in
rPepO-induced innate immunity still needs further exploration.
We are also investigating the evidence of direct binding site of
rPepO to TLR2 and TLR4.
Both TLR2 and TLR4 signaling pathways rely on TIRAP-
MyD88- IRAK- TRAF6, which leads to the phosphorylation of
NF-κB and MAPKs. Additionally TLR4 signaling can be also
mediated by TRAM-TRIF adaptor complex (Akira and Takeda,
2004; Ashall et al., 2009). Our studies showed that rPepO induced
activation of MAPKs, PI3K/Akt and NF-κB. These intracellular
messenger molecules were phosphorylated rapidly in response
to rPepO. There was no significant difference in activation of
MAPKs and Akt among WT, TLR2 deficient and TLR4 deficient
PEMs, implying that the rPepO-induced activation of innate
immunity likely mediated by both TLR2 and TLR4. Either TLR2
or TLR4 signaling can result in the phosphorylation of MAPKs
and Akt (Akira and Takeda, 2004). While rPepO failed to induce
translocation of p65 to the nucleus and phosphorylation of p65
in TLR2 or TLR4 deficient PEMs, suggesting the non- redundant
role of TLR2 and TLR4 played in rPepO-induced innate immune
response. Furthermore, rPepO-induced cytokine production was
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FIGURE 7 | rPepO induces nuclear translocation and phosphorylation of p65 in a TLR2 and TLR4 dependent manner. Immunofluorescence (A) and
western blot assays (B) were performed to determine the translocation and phosphorylation of NF-κB p65 in WT, TLR2 or TLR4 deficient PEMs. Representative blots
of three independent experiments with consistent outcome are shown. The relative band intensities of three tests are shown in histograms above. Lamin B was used
as a loading control for nuclear fractions. The data are shown as the mean ± SD (n = 3). Student’s t-test was performed to calculate the statistical significance
(**p < 0.01; ***p < 0.001).
partially mediated by p38/MAPK and PI3K/Akt signaling, and
mainly mediated by NF-κB p65 signaling. Cytokine production
was partially blocked by p38 inhibitor and PI3K inhibitor
(50–70% inhibition), but almost completely blocked by IκB-α
phosphorylation inhibitor (above 90% inhibition). Compared
with WT PEMs, rPepO– treated TLR2 deficient cells showed
delayed activation of Akt and abolished phosphorylation of
p65, while TLR4 deficient cells showed shorter duration of p38
signaling and ablated activation of p65, which may account for
their impaired cytokines production.
It is worth noting that an equal amount of rPepO failed
to activate NF-κB p65 in TLR2 or TLR4-deficient PEMs. NF-
κB regulates responses to pathogens and stresses in many
mammalian cell types and it is the main transcription factor
phosphorylated in TLRs signaling. The dimeric transcription
factor is composed of five Rel family proteins (Ashall et al., 2009).
Among these NF-κB proteins only p50 and p65 (also known
as RelA) are readily detectable in lung nuclear fractions during
acute pulmonary inflammation (Blackwell et al., 1999; Mizgerd
et al., 2002; Jones et al., 2005). P65 promotes the expression
of inflammatory cytokines to drive inflammatory responses,
and p65 deficient mice suffers severely impaired antibacterial
defense (Quinton et al., 2007). Besides, in mouse models of
pneumococcal infection inhibition of NF-κB activation helps
with bacterial growth and increases lethality (Quinton et al.,
2007). In the present study, the fast activation of p65 may play
a protective role in rPepO-induced innate immune response
in PEMs. The failure of activation of P65 in TLR2 and TLR4
deficient cells could in some extent account for the intensified
tissue injury in TLR2 and TLR4 deficient mice.
Previous researches have demonstrated that TLR activation in
B cells is an important mediator of antibody responses against
certain adjuvant vaccines (Pasare and Medzhitov, 2005; Kasturi
et al., 2011). Consistently, the notion is supported by the recent
data that flagellin ligands to TLR5 to act directly on activated
B cells (Oh et al., 2014). As a TLR4 agonist, pneumococcal Ply
has been proved to be a potent vaccine adjuvant (Douce et al.,
2010). rPepO is a TLR2 and TLR4 agonist, whether it can be a
vaccine adjuvant candidate still needs further investigation. We
have demonstrated that rPepO stimulates the release of CXCL10,
a TRIF-dependent type I interferon-inducible chemokine, which
proves the activation of TRIF-dependent signaling in rPepO-
induced innate immune response. And TRIF-mediated signaling
results in less toxic immune stimulatory responses which is
beneficial in boosting vaccine responses (Bordon, 2014; Kolb
et al., 2014). So rPepO could be a vaccine adjuvant candidate.
Overall, our work has demonstrated for the first time the roles
of a newer pneumococcal virulent factor, PepO, in activation of
host innate immunity. We prove that rPepO induces strong host
defense responses both in vivo and in vitro partially through the
TLR2 and TLR4-signaling pathways. We also clarify the related
molecular mechanism involved in the process.
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FIGURE 8 | rPepO-induced cytokines production depends primarily on the activation of p38, Akt and NF-κB. (A–D) PEMs were pretreated with SP600125,
U0126, SB203508, LY294002, AG490, and BAY11-7082 for 60min, and incubated with rPepO (10µg /ml) for another 24 hr. Cytokines production (TNF-α, IL-6,
CXCL1, and CXCL10) were measured by ELISA. The data are shown as the mean ± SD (n = 3). Student’s t-test was performed to calculate the statistical significance
(**p < 0.01; ***p < 0.001).
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